CKD-MBD II

Autor: T. Fujii, S. Suzuki, M. Shinozaki, H. Tanaka, S. Bell, S. Cooper, C. Lomonte, P. Libutti, D. Chimienti, F. Casucci, A. Bruno, M. Antonelli, P. Lisi, L. Cocola, C. Basile, A. Negri, E. Del Valle, M. Zanchetta, J. Zanchetta, M. C. Di Vico, M. Ferraresi, A. Pia, E. Aroasio, S. Gonella, E. Mongilardi, R. Clari, I. Moro, G. B. Piccoli, E. Gonzalez-Parra, L. Rodriguez-Osorio, A. Ortiz-Arduan, C. de la Piedra, J. Egido, M. V. Perez Gomez, A. A. Tabikh, B. Afsar, A. Kirkpantur, Y. Imanishi, M. Yamagata, Y. Nagata, M. Ohara, T. Michigami, T. Yukimura, M. Inaba, B. Bieber, B. Robinson, L. Mariani, S. Jacobson, L. Frimat, J. Bommer, R. Pisoni, F. Tentori, P. Ciceri, F. Elli, D. Brancaccio, M. Cozzolino, M. Adamczak, A. Wiecek, P. Kuczera, S. Sezer, Z. Bal, E. Tutal, O. Kal, D. Yavuz, I. Y ld r m, B. Sayin, R. Ozelsancak, S. Ozkurt, S. Turk, N. Ozdemir, R. Lehmann, M. Roesel, P. Fritz, N. Braun, C. Ulmer, W. Steurer, B. Dagmar, G. Ott, J. Dippon, D. Alscher, M. Kimmel, J. Latus, A. Turkvatan, M. Balci, S. Mandiroglu, B. Seloglu, M. Alkis, M. Serin, Y. Calik, S. Erkula, H. Gorboz, F. Mandiroglu, E. Lindley, M. Cruz Casal, S. Rogers, J. Pancirova, J. Kernc, J. B. Copley, D. Fouque, I. Kiss, Z. Kiss, A. Szabo, J. Szegedi, J. Balla, E. Ladanyi, B. Csiky, O. orkossy, M. Torok, S. Turi, C. Ambrus, G. Deak, A. Tisler, I. Kulcsar, V. K d r, A. Altuntas, A. Akp nar, H. Orhan, M. Sezer, V. Filiopoulos, N. Manolios, D. Arvanitis, I. Pani, K. Panagiotopoulos, D. Vlassopoulos, M. E. Rodriguez-Ortiz, A. Canalejo, C. Herencia, J. M. Martinez-Moreno, A. Peralta-Ramirez, P. Perez-Martinez, J. F. Navarro-Gonzalez, M. Rodriguez, M. Peter, K. Gundlach, S. Steppan, J. Passlick-Deetjen, J. R. Munoz-Castaneda, Y. Almaden, M. Rodriguez-Ortiz, J. Martinez-Moreno, I. Lopez, E. Aguilera-Tejero, N. Hanafusa, I. Masakane, S. Ito, S. Nakai, K. Maeda, H. Suzuki, M. Tsunoda, R. Ikee, N. Sasaki, M. Sato, N. Hashimoto, M.-H. Wang, K.-Y. Hung, C.-K. Chiang, J.-W. Huang, K.-C. Lu, C.-L. Lang, K. Okano, T. Yamashita, Y. Tsuruta, A. Hibi, N. Miwa, N. Kimata, K. Tsuchiya, K. Nitta, T. Akiba, L. Harb, H. Komaba, T. Kakuta, T. Suga, M. Fukagawa, H. Kikuchi, H. Shimada, R. Karasawa, M. Suzuki, M. Zhelyazkova-Savova, D. Gerova, D. Paskalev, V. Ikonomov, R. Zortcheva, B. Galunska, G. Jean, P. Deleaval, J.-M. Hurot, C. Lorriaux, B. Mayor, C. Chazot, H. Vannucchi, M. T. Vannucchi, J. C. Martins, J. L. Merino, J. L. Teruel, M. Fernandez-Lucas, J. J. Villafruela, B. Bueno, A. Gomis, V. Paraiso, C. Quereda, F. H. Ibrahim, N. Z. Fadhlina, E. K. Ng, K. M. Thong, B. L. Goh, D. M. Sulaiman, D. A. N. Fatimah, D. O. Evi, S. R. Siti, R. J. Wilson, M. Keith, B. Gros, A. Galan, J. A. Herrero, I. Oyaguez, M. A. Casado, S. Lucisano, G. Coppolino, A. Villari, V. Cernaro, R. Lupica, D. Trimboli, C. Aloisi, M. Buemi

Publikováno v: Nephrology Dialysis Transplantation. 28:i460-i471

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::97e1a9d817c969b8452b097c455e257b
https://doi.org/10.1093/ndt/gft149

Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients

Autor: Roberto Marcén, J L Teruel, J Navarro-Antolin, Abelardo Aguilera, Joaquín Ortuño, Gema Fernández-Juárez

Publikováno v: Journal of the American Society of Nephrology. 7:140-144

According to this facility's protocol for the treatment of anemia in hemodialyzed patients, androgens were administered to male patients aged over 50 yr and recombinant human erythropoietin was administered to male patients below 50 yr of age and to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e48d8f0cb5347507967635d6791d024
https://doi.org/10.1681/asn.v71140

Causes of unplanned hemodialysis initiation

Autor: A, Gomis Couto, J L, Teruel Briones, M, Fernández Lucas, M, Rivera Gorrin, N, Rodríguez Mendiola, S, Jiménez Álvaro, C, Quereda Rodríguez-Navarro

Publikováno v: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 31(6)

Half of patients starting chronic hemodialysis used a transient vascular catheter as a vascular access (unplanned initiation). An objective of the Quality Management Group of the Spanish Society of Nephrology is to achieve that 80% of the patients st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1254184d0175ab732af56d3f78e1f45d
https://pubmed.ncbi.nlm.nih.gov/22130290

Dialysis after kidney transplant failure: do patients start in a worse condition than the general population with chronic kidney disease?

Autor: S, Caldés Ruisánchez, R, Marcén Letosa, Y, Amezquita Orjuela, M, Fernández Lucas, M, Rivera Gorrin, C, Galeano Álvarez, A, Fernández Rodríguez, J L, Teruel Briones, C, Quereda Rodríguez-Navarro

Publikováno v: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 31(1)

Patients with renal graft dysfunction constitute an increasingly prevalent group of end-stage kidney disease (ESKD) patients that require dialysis therapy. These patients have special characteristics that set them apart from the ESKD general populati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2fd8018c381524a2e11152c60efe731a
https://pubmed.ncbi.nlm.nih.gov/21270913

Blood Pressure after three Different forms of Correction of Anemia in Hemodialysis

Autor: R. Marcén, Liaño F, J. Ortuño, J L Teruel, J Pascual

Publikováno v: The International Journal of Artificial Organs. 15:393-396

It is not known whether recombinant human erythropoietin has a direct, clinically apparent pressor effect in hemodialysis patients or whether hypertension developing or aggravated in these patients merely reflects increased hematocrit. We compared bl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e5acedd8067409c93c516c9a2d84e4e4
https://doi.org/10.1177/039139889201500703